US Stock MarketDetailed Quotes

TERN Terns Pharmaceuticals

Watchlist
  • 3.339
  • -0.171-4.87%
Trading Mar 25 13:05 ET
291.50MMarket Cap-2.98P/E (TTM)

Terns Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-0.67%101.87M
7.86%25.95M
-24.85%24.94M
20.69%25.54M
5.34%25.45M
65.34%102.56M
42.96%24.06M
91.90%33.18M
50.23%21.16M
74.73%24.16M
Selling and administrative expenses
-18.69%31.76M
20.40%7.95M
-46.77%9.77M
2.53%7.19M
-3.41%6.86M
74.29%39.06M
6.95%6.6M
257.69%18.35M
29.25%7.01M
24.82%7.1M
-General and administrative expense
-18.69%31.76M
20.40%7.95M
-46.77%9.77M
2.53%7.19M
-3.41%6.86M
74.29%39.06M
6.95%6.6M
257.69%18.35M
29.25%7.01M
24.82%7.1M
Research and development costs
10.42%70.11M
3.12%18M
2.28%15.17M
29.69%18.35M
8.98%18.59M
60.28%63.5M
63.81%17.46M
21.96%14.83M
63.37%14.15M
109.64%17.06M
Operating profit
0.67%-101.87M
-7.86%-25.95M
24.85%-24.94M
-20.69%-25.54M
-5.34%-25.45M
-65.34%-102.56M
-42.96%-24.06M
-91.90%-33.18M
-50.23%-21.16M
-74.73%-24.16M
Net non-operating interest income expense
3.01%13.29M
24.30%4.14M
-11.26%3.09M
-15.29%2.88M
18.16%3.18M
511.42%12.9M
150.98%3.33M
597.39%3.48M
1,486.45%3.4M
3,802.90%2.69M
Non-operating interest income
3.01%13.29M
24.30%4.14M
-11.26%3.09M
-15.29%2.88M
18.16%3.18M
511.42%12.9M
150.98%3.33M
597.39%3.48M
1,486.45%3.4M
3,802.90%2.69M
Other net income (expense)
96.50%-11K
119.18%47K
-540.00%-32K
76.67%-14K
-200.00%-12K
-361.76%-314K
-6,025.00%-245K
64.29%-5K
-11.11%-60K
-200.00%-4K
Other non- operating income (expenses)
96.50%-11K
119.18%47K
-540.00%-32K
76.67%-14K
-200.00%-12K
-361.76%-314K
-6,025.00%-245K
64.29%-5K
-11.11%-60K
-200.00%-4K
Income before tax
1.53%-88.59M
-3.76%-21.76M
26.34%-21.88M
-27.22%-22.68M
-3.76%-22.28M
-49.98%-89.97M
-35.26%-20.97M
-76.77%-29.71M
-28.01%-17.82M
-56.11%-21.47M
Income tax
8.79%260K
-18.37%40K
6.90%62K
-15.28%61K
61.67%97K
-33.24%239K
-84.59%49K
346.15%58K
1,100.00%72K
185.71%60K
Net income
1.50%-88.85M
-3.71%-21.8M
26.28%-21.95M
-27.05%-22.74M
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
Net income continuous Operations
1.50%-88.85M
-3.71%-21.8M
26.28%-21.95M
-27.05%-22.74M
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
Minority interest income
Net income attributable to the parent company
1.50%-88.85M
-3.71%-21.8M
26.28%-21.95M
-27.05%-22.74M
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1.50%-88.85M
-3.71%-21.8M
26.28%-21.95M
-27.05%-22.74M
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
Basic earnings per share
11.81%-1.12
17.24%-0.24
33.33%-0.28
-24.00%-0.31
3.23%-0.3
23.95%-1.27
0.00%-0.29
4.55%-0.42
54.55%-0.25
43.64%-0.31
Diluted earnings per share
11.81%-1.12
17.24%-0.24
33.33%-0.28
-24.00%-0.31
3.23%-0.3
23.95%-1.27
0.00%-0.29
4.55%-0.42
54.55%-0.25
43.64%-0.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -0.67%101.87M7.86%25.95M-24.85%24.94M20.69%25.54M5.34%25.45M65.34%102.56M42.96%24.06M91.90%33.18M50.23%21.16M74.73%24.16M
Selling and administrative expenses -18.69%31.76M20.40%7.95M-46.77%9.77M2.53%7.19M-3.41%6.86M74.29%39.06M6.95%6.6M257.69%18.35M29.25%7.01M24.82%7.1M
-General and administrative expense -18.69%31.76M20.40%7.95M-46.77%9.77M2.53%7.19M-3.41%6.86M74.29%39.06M6.95%6.6M257.69%18.35M29.25%7.01M24.82%7.1M
Research and development costs 10.42%70.11M3.12%18M2.28%15.17M29.69%18.35M8.98%18.59M60.28%63.5M63.81%17.46M21.96%14.83M63.37%14.15M109.64%17.06M
Operating profit 0.67%-101.87M-7.86%-25.95M24.85%-24.94M-20.69%-25.54M-5.34%-25.45M-65.34%-102.56M-42.96%-24.06M-91.90%-33.18M-50.23%-21.16M-74.73%-24.16M
Net non-operating interest income expense 3.01%13.29M24.30%4.14M-11.26%3.09M-15.29%2.88M18.16%3.18M511.42%12.9M150.98%3.33M597.39%3.48M1,486.45%3.4M3,802.90%2.69M
Non-operating interest income 3.01%13.29M24.30%4.14M-11.26%3.09M-15.29%2.88M18.16%3.18M511.42%12.9M150.98%3.33M597.39%3.48M1,486.45%3.4M3,802.90%2.69M
Other net income (expense) 96.50%-11K119.18%47K-540.00%-32K76.67%-14K-200.00%-12K-361.76%-314K-6,025.00%-245K64.29%-5K-11.11%-60K-200.00%-4K
Other non- operating income (expenses) 96.50%-11K119.18%47K-540.00%-32K76.67%-14K-200.00%-12K-361.76%-314K-6,025.00%-245K64.29%-5K-11.11%-60K-200.00%-4K
Income before tax 1.53%-88.59M-3.76%-21.76M26.34%-21.88M-27.22%-22.68M-3.76%-22.28M-49.98%-89.97M-35.26%-20.97M-76.77%-29.71M-28.01%-17.82M-56.11%-21.47M
Income tax 8.79%260K-18.37%40K6.90%62K-15.28%61K61.67%97K-33.24%239K-84.59%49K346.15%58K1,100.00%72K185.71%60K
Net income 1.50%-88.85M-3.71%-21.8M26.28%-21.95M-27.05%-22.74M-3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M
Net income continuous Operations 1.50%-88.85M-3.71%-21.8M26.28%-21.95M-27.05%-22.74M-3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M
Minority interest income
Net income attributable to the parent company 1.50%-88.85M-3.71%-21.8M26.28%-21.95M-27.05%-22.74M-3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1.50%-88.85M-3.71%-21.8M26.28%-21.95M-27.05%-22.74M-3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M
Basic earnings per share 11.81%-1.1217.24%-0.2433.33%-0.28-24.00%-0.313.23%-0.323.95%-1.270.00%-0.294.55%-0.4254.55%-0.2543.64%-0.31
Diluted earnings per share 11.81%-1.1217.24%-0.2433.33%-0.28-24.00%-0.313.23%-0.323.95%-1.270.00%-0.294.55%-0.4254.55%-0.2543.64%-0.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
+2.72%
Ecopetrol
EC
+2.53%
Adobe
ADBE
+2.14%
Strategy
MSTR
+1.84%
Meta Platforms
META
+1.67%

Unlock the Full List